Stanford Pragmatic Effectiveness Comparison

Summary

Stanford Pragmatic Effectiveness Comparison is a clinical trial^[1].

Key Facts

• Stanford Pragmatic Effectiveness Comparison is in the country of United States^[2].
• Stanford Pragmatic Effectiveness Comparison's instance of is recorded as clinical trial^[3].
• Stanford Pragmatic Effectiveness Comparison's start time is recorded as +2021-04-01T00:00:00Z^[4].
• Stanford Pragmatic Effectiveness Comparison's end time is recorded as +2026-03-31T00:00:00Z^[5].
• Stanford Pragmatic Effectiveness Comparison's sponsor is recorded as Stanford University^[6].
• Stanford Pragmatic Effectiveness Comparison's main subject is recorded as chronic pain^[7].
• Stanford Pragmatic Effectiveness Comparison's number of participants is recorded as {'unit': '1', 'amount': '+450'}^[8].
• Stanford Pragmatic Effectiveness Comparison's title is recorded as Integrating Pragmatic Comparative Effectiveness Research Into a Tertiary Pain Management Center^[9].
• Stanford Pragmatic Effectiveness Comparison's short name is recorded as SPEC-AA^[10].
• Stanford Pragmatic Effectiveness Comparison's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Stanford Pragmatic Effectiveness Comparison's ClinicalTrials.gov ID is recorded as NCT04441034^[12].
• Stanford Pragmatic Effectiveness Comparison's research intervention is recorded as convulsant^[13].
• Stanford Pragmatic Effectiveness Comparison's research intervention is recorded as second-generation antidepressive agents^[14].
• Stanford Pragmatic Effectiveness Comparison's research intervention is recorded as anticonvulsant agent^[15].
• Stanford Pragmatic Effectiveness Comparison's clinical trial phase is recorded as phase IV clinical trial^[16].
• Stanford Pragmatic Effectiveness Comparison's research subject recruitment status is recorded as not yet recruiting^[17].
• Stanford Pragmatic Effectiveness Comparison's study type is recorded as interventional study^[18].